4/11/2019China Plans to Issue A New Set of Standards for Stem Cell Therapies

4/11/2019Synaffix Announces $125M License Agreement with Shanghai Miracogen

4/11/2019Catalent Opens 2nd Shanghai Facility to Optimize Clinical Supply Solut...

4/10/2019HitGen and Kaken Enter into License Agreement for Novel Drug Developme...

4/10/2019ReNeuron Licenses China Rights of Cell Therapy Programs to Fosun Pharm...

4/10/2019NHC Issues Notice on Implementing Drug Consumption Surveillance and Ov...

4/10/2019NDRC Solicits Comments on 2019 Edition of Guiding Catalogue for the Ad...

4/10/2019BioAtla and BeiGene Form Global Collaboration for Novel Conditionally ...

4/10/2019Chongqing Zhifei Bio Halts Production after Delay in License Renewal

4/10/2019Sanofi CEO Pledges More Investment, R&D Facility and 16 New Drugs ...

4/10/2019Sanofi Hopes to Catch Up with Digital Healthcare Service in China

4/10/2019Auction - Pharma Site Closure in XiAn, China (Bid Due by April 12)

4/10/2019Takeda Completes China Business Restructure Following Shire Acquisitio...

4/10/2019Ascentage Announces Clinical Collaboration with Junshi Bio to Evaluate...

4/10/2019Antengene Announces U.S. Subsidiary and Collaboration with the Blumber...

4/10/2019China Improves Healthcare Resource Sharing Thru Increased Cooperation ...

4/5/2019Upcoming Event: Pharma China Annual Forum 2019 (April 9, Shanghai)

4/5/2019NMPA Solicits Comments on New Document on Linked Evaluation and Approv...

4/5/2019Recent Executive Moves

4/4/2019NMPA Issues New Announcement (2019#21) for Clinical Data Self-Inspecti...

4/3/2019Deloitte Report: The Future of Life Sciences and Health Care in Asia P...

4/3/2019Novartis CEO Expects China to Become One of Its Three Top Markets in t...

4/3/2019FDA'S Pazdur Encourages Chinese Companies To Bring Low-Cost PD-1 Drugs...

4/3/2019PharmExec: Use of External Innovation in China

4/3/2019Adlai Nortye Receives NMPA Approval for Phase III Trials of Pelareorep

4/3/2019Sichuan Haisco Acquires Stake in eXithera and Right to Its Novel Anti-...

4/3/2019China to Regulate All Fentanyl Drugs as Controlled Substance

4/3/2019Savolitinib Co-developed by Chi-Med and AZ Helpful to Some Tagrisso-r...

4/2/2019State Council Approves Establishment of the System of Inter-ministeria...

4/1/2019MSD's KEYTRUDA Approved in China for First-Line Treatment of NSCLC in ...

Page:287/775 Total number of articles:23233: [First][<<] [285] [286] [287] [288] [289] [>>] [End]